Danger Dust

234 readers

37 users here now

A community for those occupationally exposed to dusts, toxins, pollutants, hazardous materials or noxious environments

Dangerous Dusts , Fibres, Toxins, Pollutants, Occupational Hazards, Stonemasonry, Construction News and Environmental Issues

#Occupational Diseases

#Autoimmune Diseases

#Silicosis

#Cancer

#COPD

#Chronic Fatigue

#Hazardous Materials

#Kidney Disease

#Pneumoconiosis

#The Environment

#Pollutants

#Pesticides

and more

Please be nice to each other and follow the rules : []https://mastodon.world/about

founded 1 year ago

MODERATORS

Bampot

Scientists warn of a “Tsunami” of osteoarthritis cases by 2050 (www.cost.eu)

submitted 8 months ago by Bampot to c/dangerdust

5 comments fedilink hide all child comments

Although osteoarthritis affects more than 500 million people in the world, according to the World Health Organisation, there is no cure or any approved drugs to treat or prevent the disease and the only available treatments are painkillers, anti-inflammatory medications, and total joint replacement.

By the year 2050 1 in 3 will suffer from osteoarthritis, and to this day, there is no cure.

Therefore, the aim of the NetwOArk COST Action – The Open European Network on OsteoArthritis – is to set up a European Society for Osteoarthritis. Launched, in October 2022, the network gathers patients, clinicians, and researchers, from academia and industry in 17 countries. NetwOArk intends to build an inclusive network and a new society that brings together all the major key players, including patients, patient advocacy groups, scientists, doctors, pharmaceutical companies, small and medium-sized enterprises, medical device manufacturers, and policymakers.

you are viewing a single comment's thread
view the rest of the comments

[–] JBar2 2 points 8 months ago

Interestingly, orthopedic market analysts are simultaneously warning of potential headwinds in the number of orthopedic surgeries due to the anticipated growth in the use of Ozempic and similar drugs. These weight-loss drugs will reduce the stress on joints such as hips, knees, and vertebrae, delaying, and in some cases eliminating, the need for orthopedic surgery.

Of course, there are many factors at play including the aging population, the rate of increase of prescriptions, whether insurers eventually cover the use of such drugs, and the manufacturers' ability to keep up with the demand.